LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies

Clinical trial NCT02699190 · COMPLETED

Trial details

NCT number: NCT02699190
Sponsor: Children's Hospital of Philadelphia
Status: COMPLETED
Study type: OBSERVATIONAL

Leukodystrophy White Matter Disease 4H Syndrome Adrenoleukodystrophy AMN ALD ALD (Adrenoleukodystrophy)X-linked Adrenoleukodystrophy X-ALD Adrenomyeloneuropathy Aicardi Goutieres Syndrome AGS

Start date: 2017-01-06
Primary completion: 2023-10-31
Enrollment: 236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.